Vertex Announces Webcast of its Presentation at the Goldman Sachs 34th Annual Global Healthcare Conf
Vertex Announces Webcast of its Presentation at the Goldman Sachs 34th Annual Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (NAS: VRTX) today announced that it will webcast its presentation at the Goldman Sachs 34th Annual Global Healthcare Conference on Tuesday, June 11, 2013 at 10:00 AM (PT).
The presentation will be webcast live and may be accessed from the 'Events & Presentations' link under the 'Investors' tab on the home page of Vertex's website at www.vrtx.com. A replay of the webcast will also be available on the Company's website for two weeks following the presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, Mass., we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and for three years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences.
Vertex's press releases are available at www.vrtx.com.
Vertex Pharmaceuticals Incorporated
Kelly Lewis, 617-961-7530
Director, Investor Relations
KEYWORDS: United States North America Massachusetts
The article Vertex Announces Webcast of its Presentation at the Goldman Sachs 34th Annual Global Healthcare Conference originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.